Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point.
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation.
Townsend RR, Walton A, Hettrick DA, Hickey GL, Weil J, Sharp ASP, Blankestijn PJ, Böhm M, Mancia G.
EuroIntervention. 2020 May 20;16(1):89-96. doi: 10.4244/EIJ-D-19-00902.
PMID:32038027
Editorial Comment to Randomized trials to determine the ideal management of the renal artery during partial nephrectomy: Life's under no obligation to give us what we expect.
Campi R, Amparore D; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.
Int J Urol. 2022 Jan;29(1):93-94. doi: 10.1111/iju.14739. Epub 2021 Nov 5.
PMID:34738255
Endovascular therapy for distal hilar renal artery aneurysm: a case report and literature review.
Ye P, Wu H, Chen Y, Li Y, Cai C, Lv P.
J Int Med Res. 2022 Jan;50(1):3000605211069282. doi: 10.1177/03000605211069282.
PMID:35023377
Frequency of renal artery stenosis after renal denervation in patients with resistant arterial hypertension.
Lambert T, Nahler A, Reiter C, Schwarz S, Gammer V, Blessberger H, Kammler J, Saleh K, Grund M, Steinwender C.
Am J Cardiol. 2015 Jun 1;115(11):1545-8. doi: 10.1016/j.amjcard.2015.02.055. Epub 2015 Mar 12.